Our Story

Lumanity was formed to bring together diverse perspectives and unique clinical, scientific, and functional expertise to uncover innovative, yet pragmatic approaches to address the complex set of challenges on the path to market.
Join us
Our Focus

Learn more about why Lumanity came together to accelerate and unlock innovative new solutions for our clients. We have been illuminating new possibilities and driving impact for global clients for over 30 years.

Decorative yellow brand motif
Diverse Problem Solvers

Our industry sits at a tipping point. The unprecedented growth of medical innovation is resulting in a diverse complex set of challenges on the path to market. The product development, market access, and commercialization models of the past are not suitable to allow humanity to realize the benefits of today’s extraordinary medical breakthroughs. Innovative therapies need innovative solutions.

Lumanity was formed to bring together diverse perspectives and unique clinical, scientific, and functional expertise to uncover innovative, yet pragmatic approaches to address these challenges.

Diverse industry experts

Lumanity brings together and builds upon a unique and diverse team of 1,300+ deeply experienced industry pioneers, data luminaries, subject matter experts, and proven problem-solvers from exceptional legacy organizations, including: Cello Health, BresMed, Guidemark Health, Cyan Health, Zipher Medical Affairs, IE, Endpoint Outcomes, and Clarion. Together, we are Lumanity.

With offices in North America, the United Kingdom, European Union, and Asia, and work conducted in over 50 countries, we work with nearly all of the top pharmaceutical companies and more than 100 biotech companies around the world. Every year, Lumanity supports over 50 payer submissions across 20+ countries, launch readiness and commercialization of over 80 brands and new indications, and numerous award-winning product campaigns.

24
Partnering with 24 of the top 25 global pharma companies
1300+
Scientists, communicators, researchers, strategists, storytellers, and problem-solvers with work conducted in over 50 countries
100+
Supporting 100+ small, start-ups, and emerging biotechs
150+
Credentialed scientists; PhDs, PharmDs and MDs providing a depth of understanding into cutting edge science

Meet our team

Leadership
Meet the team that is bringing incisive thinking and decisive action to clients.
Learn more
People
Meet the people that illuminate new possibilities and help accelerate access to the treatments that transform lives.
Learn more
Recognition
Honoring Excellence in Advertising 2022
Leith, a Lumanity business, received a Grand Clio Award in 2022 for their creative on raising awareness on how to perform CPR.
1 / 7
UK's Leading Management Consultants 2023
Lumanity was recognized as one of the UK's Leading Management Consultants in 2023 by the Financial Times.
2 / 7
Top Pharma and Life Sciences Consulting Firms
Lumanity was recognized as one of the leading consulting firms in the UK in 2023 by Consultancy.uk.
3 / 7
Diversity, Equity and Inclusion
Lumanity’s Diversity, Equity, and Inclusion Center of Excellence received a "Highly Commended" designation for bringing DEI to life and elevating it as a corporate cornerstone within the company.
4 / 7
Most Creative Marketing and Media
Guidemark, now Lumanity, was recognized as one of MM&M's Top 100 companies, as well as their 40 Under 40 award.
5 / 7
Best Creative and Digital Communications
Lumanity businesses have received numerous awards from the PM Society for its creative patient and HCP communication campaigns over the last several years.
6 / 7
Power of Marketing Excellence
Lumanity businesses have received numerous awards from The Marketing Society for its innovative and results-driven achievements.
7 / 7

Explore our latest insights

View all perspectives
Half-time in the EU HTA Regulation Roll Out
In this whitepaper, published halfway through the European Union Health Technology Assessment Regulation preparatory phase running from January 2022 to January 2025, we summarize what we know of the EU HTA Regulation so far, and consider some of the uncertainties that remain.
Whitepaper Sep 22, 2023